Brief: Amphastar Pharmaceuticals Reports Q3 EPS Of $0.08

Amphastar Pharmaceuticals,

06/11/2020 12:21

Nov 6 (Reuters) - Amphastar Pharmaceuticals Inc  AMPH.O :
    * AMPHASTAR PHARMACEUTICALS REPORTS FINANCIAL RESULTS FOR
THE
THREE MONTHS ENDED SEPTEMBER 30, 2020
    * Q3 GAAP EARNINGS PER SHARE $0.08
    * Q3 REVENUE $83.4 MILLION VERSUS REFINITIV IBES ESTIMATE OF
$91.3
MILLION
    * Q3 EARNINGS PER SHARE ESTIMATE $0.14 -- REFINITIV IBES
DATA
    * Q3 ADJUSTED NON-GAAP EARNINGS PER SHARE $0.15
    * HAS NOT EXPERIENCED ANY SIGNIFICANT NEGATIVE IMPACTS ON
ITS CASH
FLOWS OR OPERATIONS AS A RESULT OF COVID-19
    * PRODUCTION FACILITIES CONTINUED TO OPERATE DURING QUARTER
AS
THEY HAD PRIOR TO PANDEMIC WITH VERY LITTLE CHANGE

Source text for Eikon:  ID:nGNX5MKMhL 
Further company coverage:  AMPH.O 

 ((Reuters.Briefs@thomsonreuters.com;))